3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other solid neoplasm
1
Conditions
Multiple Myeloma
124
Lymphoma
71
Lymphoma, Non-Hodgkin
58
Precursor Cell Lymphoblastic Leukemia-Lymphoma
52
Leukemia, Myeloid, Acute
52
Myelodysplastic Syndromes
50
Neoplasms, Plasma Cell
48
Hodgkin Disease
48
Leukemia
42
Leukemia, Lymphocytic, Chronic, B-Cell
40
Lymphoma, Mantle-Cell
35
Lymphoma, Large B-Cell, Diffuse
35
Lymphoma, Follicular
33
Burkitt Lymphoma
24
Lymphoma, B-Cell, Marginal Zone
22
Lymphoma, Large-Cell, Immunoblastic
21
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
21
Myeloproliferative Disorders
20
Recurrence
19
Hematologic Neoplasms
19
Immunoglobulin Light-chain Amyloidosis
18
Leukemia, Myelomonocytic, Chronic
16
Neuroblastoma
15
Leukemia, Myeloid, Chronic-Phase
15
Leukemia, Myeloid, Accelerated Phase
15
Graft vs Host Disease
15
Dendritic Cell Sarcoma, Interdigitating
15
Anemia, Refractory, with Excess of Blasts
14
Waldenstrom Macroglobulinemia
12
Primary Myelofibrosis
12
Interventions
Etoposide
2
Carboplatin
2
Vincristine
1
Platinum Compounds
1
Melphalan
1
Lasers, Semiconductor
1
Lasers
1
Drug Therapy
1
Cryotherapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
Retinal Neoplasms
×
Melphalan
×
Clear all
NCT02866136
2025-11-24
RETINO2011
Institut Curie
Phase 2
Active not recruiting
133 enrolled